Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAeci 5 1/2% Prf Regulatory News (87FZ)

Share Price Information for Aeci 5 1/2% Prf (87FZ)

Share Price is delayed by 15 minutes
Get Live Data
65.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
87FZ Live PriceLast checked at - London Stock Exchange

Intraday Aeci 5 1/2% Prf Share Chart

Statement re Acquisition

27 Jun 2012 14:00

AECI LIMITED Incorporated in the Republic of South Africa (Registration No. 1924/002590/06) Share code: AFE ISIN No. ZAE000000220 ("AECI")

AECI ACQUIRES WATER TREATMENT BUSINESS IN AFRICA

AECI has acquired General Electric's world-class Chemical and Monitoring Solutions business in Africa, for a total consideration of US$20 million. The acquisition is effective from 1 July 2012 and will be merged into ImproChem, which is leading the AECI Group's strategic growth thrust to become the supplier of choice for specialty water treatment and process chemicals and services in Africa.

The geographies covered by the transaction are Africa and the Indian Ocean islands of Madagascar, Mauritius and Reunion. This target market has an estimated combined annual value in excess of US$500 million and is growing at 12% a year. Excluded from the transaction are businesses in Egypt, Libya, Tunisia, Algeria and Morocco.

ImproChem provides integrated water, energy and air solutions to the chemical, refining, petrochemical, mining and food and beverage industries. It is has a well-established footprint in Africa and the agreement with General Electric (GE) will ensure that customers in this region, where water is often a scarce resource, continue to have access to the most advanced technologies that enhance the efficiencies of their operations while reducing operating costs.

AECI and GE have also entered into an exclusive distribution agreement and a licensing arrangement that provide GE with continued direct involvement with the business. As part of the agreement, ImproChem will produce chemical products using GE formulations at its Umbogintwini plant. GE will also have the right to consider forming a Joint Venture with ImproChem in the future. GE remains committed to the CMS business, as demonstrated by its continued investment in CMS research and development and in its CMS commercial sales and distribution channels.

GE entered into a non-exclusive distribution arrangement with ImproChem in October 2011. This new transaction builds on that solid foundation and both GE and AECI believe that the new arrangement provides greater opportunities than either company could offer alone. It is well aligned with both companies' business models, both have a good reputation in the region and a well-regarded compliance culture. GE also has an experienced team of sales people in the field and strong regional capabilities that will complement ImproChem's resources.

The transaction has been approved by the necessary regulatory authorities in South Africa.

Woodmead, Sandton27 June 2012

Sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date   Source Headline
23rd Aug 202312:00 pmPRNDirector/PDMR Shareholding
1st Aug 20239:00 amPRNInterest Payment Notification
26th Jul 20237:00 amPRNUnaudited Consolidated Interim Financial Results and Cash Dividend Declaration for the half-year ended 30 June 2023
26th Jul 20237:00 amPRNDeclaration of Interim Ordinary Cash Dividend No.  179
11th Jul 202312:00 pmPRNAvailability of B-BBEE Compliance Report
29th Jun 202312:41 pmPRNVoluntary Pre-Close Period Update for the Five Months Ended 31 May 2023
28th Apr 20232:00 pmPRNNo Change Statement
1st Jun 20221:00 pmPRNBoard Committee Changes
31st May 20221:00 pmPRNResult of AGM
24th May 20229:00 amPRNPreference Dividend Declaration
6th Apr 20229:01 amPRNDealings in Securities re LTIP
5th Apr 20229:00 amPRNDealings in Securities re LTIP
30th Mar 20229:36 amPRNDealings in Securities re LTIP
17th Mar 20222:00 pmPRNHolding(s) in Company
15th Mar 20228:52 amPRNHolding(s) in Company
2nd Mar 20229:18 amPRNAvailability of Annual Results Presentation
2nd Mar 20227:00 amPRNSummarised Results for the year ended 31 Dec 2021
23rd Feb 20229:36 amPRNTrading Statement
18th Feb 202211:45 amPRNDirectorate Change
16th Feb 20221:00 pmPRNSpecific Repurchase Cancellation
8th Feb 202212:00 pmPRNInterest Payments Notification
1st Feb 202212:00 pmPRNSpecific Repurchase of Shares
25th Jan 202210:00 amPRNHolding(s) in Company
7th Dec 202110:00 amPRNInterest Payments Notification
6th Dec 20212:31 pmPRNDirector/PDMR Shareholding
23rd Nov 202110:00 amPRNPreference Dividend Declaration
16th Nov 20211:00 pmPRNHolding(s) in Company
15th Nov 20219:30 amPRNInterest Payments Notification
22nd Sep 202110:51 amPRNHolding(s) in Company
9th Sep 20212:30 pmPRNChange in the role of a Director
7th Sep 20219:05 amPRNInterest and Capital Payments Notification
3rd Sep 20218:39 amPRNHolding(s) in Company
11th Aug 20211:30 pmPRNHolding(s) in Company
5th Aug 202112:00 pmPRNInterest Payments Notification
28th Jul 20219:54 amPRNCorrection - Availability of Interim Presentation
28th Jul 20219:30 amPRNAvailability of Interim Results Presentation
28th Jul 20217:00 amPRNSummarised interim financial results to 30 June 2021
16th Jul 20211:39 pmPRNTrading Statement for 6 Months ended 30 June 2021
12th Jul 202112:00 pmPRNAvailability of B-BBEE Compliance Report
30th Jun 202111:30 amPRNAppointment of Group Company Secretary
21st Jun 20213:30 pmPRNCancellation of engagement with dissenting shareholders
17th Jun 20219:15 amPRNAppointment of Independent Non-Executive Director
4th Jun 202111:00 amPRNInterest Payments Notification
2nd Jun 20212:30 pmPRNDealings of a Director of a Major Subsidiary
2nd Jun 202110:00 amPRNSection 45(5) Notice
27th May 20217:24 amPRNResult of AGM
25th May 20218:11 amPRNPreference Dividend Declaration
10th May 20219:00 amPRNInterest Payments Notification
4th May 20217:00 amPRNDirectorate Change
30th Apr 20219:30 amPRNAcceptance of LTIP awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.